Tag: Arthritis drugs

Study: arthritis drugs’ promising result in recovery, reduced mortality from Covid-19

January 11, 2021

New findings from the study undertaken by experts from the Imperial College London have shown that arthritis medications tocilizumab and sarilumab, both IL-6 receptor antagonists can potentially improve survival outcomes of critically-ill Covid-19 patient, reduce mortality by 8.5%, as well as hasten recovery for patients. The findings, which have not yet been peer-reviewed, come from the REMAP-CAP trial, which […]

Continue Reading